AstraZeneca PLC AZN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
67.72quote price arrow down-0.03 (-0.04%)
Volume
206,198
Close
67.75UNCH (UNCH)
Volume
3,389,817
52 week range
60.47 - 76.56
Loading...
  • Open68.18
  • Day High68.35
  • Day Low67.68
  • Prev Close68.26
  • 52 Week High76.56
  • 52 Week High Date04/25/23
  • 52 Week Low60.47
  • 52 Week Low Date02/12/24

Key Stats

  • Market Cap210.053B
  • Shares Out3.10B
  • 10 Day Average Volume4.69M
  • Dividend1.45
  • Dividend Yield2.14%
  • Beta0.51
  • YTD % Change0.59

KEY STATS

  • Open68.18
  • Day High68.35
  • Day Low67.68
  • Prev Close68.26
  • 52 Week High76.56
  • 52 Week High Date04/25/23
  • 52 Week Low60.47
  • 52 Week Low Date02/12/24
  • Market Cap210.053B
  • Shares Out3.10B
  • 10 Day Average Volume4.69M
  • Dividend1.45
  • Dividend Yield2.14%
  • Beta0.51
  • YTD % Change0.59

RATIOS/PROFITABILITY

  • EPS (TTM)1.91
  • P/E (TTM)35.53
  • Fwd P/E (NTM)12.69
  • EBITDA (TTM)13.591B
  • ROE (TTM)15.63%
  • Revenue (TTM)45.811B
  • Gross Margin (TTM)82.39%
  • Net Margin (TTM)13.01%
  • Debt To Equity (MRQ)73.12%

EVENTS

  • Earnings Date04/25/2024
  • Ex Div Date02/22/2024
  • Div Amount0.985
  • Split Date-
  • Split Factor-

Profile

MORE
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and includes the Alexion Rare Disease portfolio comprising approximately 178 projects....
Michel Demare
Non-Executive Independent Chairman of the Board
Pascal Soriot
Chief Executive Officer, Executive Director
Aradhana Sarin M.D.
Chief Financial Officer, Executive Director
Ruud Dobber Ph.D.
Executive Vice President - BioPharmaceuticals Business Unit
Susan Galbraith
Executive Vice President - Oncology and Research and Development
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
NVS
Novartis AG
96.73UNCHUNCH
PFE
Pfizer Inc
27.75UNCHUNCH
RHHBY
Roche Holding AG
31.92+0.61+1.95%
SNY
Sanofi SA
48.60UNCHUNCH
BMY
Bristol-Myers Squibb Co
54.23UNCHUNCH